When:
Tuesday, Sep 25, 2018 8:00a -
Thursday, Sep 27, 2018 5:00p

Where:
Hilton Boston/Woburn
2 Forbes Road
Woburn, Massachusetts 01801

Admission:
$599

Categories:
Lectures & Conferences

Event website:
http://go.evvnt.com/243084-0?pid=5248

If you're actively invested in leveraging evidence to support drug development and commercialization, join the 6th annual IMPACCT:RWE 2018 meeting, where you will have an opportunity to explore how RWE is currently applied across the drug development continuum to support decision-making in clinical development, drug marketing and commercialization.


Today more than ever, we live in a world of mobile, digital and electronic generated data. In healthcare, real-world data provide great potential for better design and conduct of clinical trials and generate more value-based outcomes in drug development. To gain competitive advantage and achieve better outcomes, pharma and biotech organizations seek to advance the way they use RWE - real-world evidence, for the benefit of patients and commercial success of their products.


Key Reasons to attend:


1. Discover how to innovate the use of the available real-world data, and translate it into clinically meaningful effects in the real world and more evidence-based decision-making processes.


2. Share your learnings and perspectives with a focused community of industry peers.


3. Gain insight into how to plan the evidence generation to effectively support drug development and commercialization success, enhance decision making, and establish yourself as a value generating organization.


4. Contribute to collaboratively advance the 'impacct' of RWE in drug development, patient-centricity, and product life-cycle.


5. Learn how RWE can be applied across the drug development continuum, particularly in clinical development, drug marketing and commercialization stages.


Take a look at the full program to preview 18+ focused case studies, expert speaker line-up and attendance breakdown:: https://goo.gl/cUZk8L


URLs:
Tickets: https://go.evvnt.com/243084-1?pid=5248
Website: https://go.evvnt.com/243084-3?pid=5248


Price
Conference Only: USD 2499.0
Conference Plus Workshop: USD 2998.0
Workshop Only: USD 599.0


Speakers: Ann Hartry, VP, US HEOR & RWE, Lundbeck, Kourtney Davis, Senior Director & Global Head of RWD & Analytics, GSK, Christoph Koenen, Head of Cardiovascular Development, Therapeutic Area Head, BMS, Shanthy Krishnarajah, Senior Director, Global Health Economics & Reimbursement Strategy, CSL Behring, Frank Zhang, VP Market Access - Global Strategy & US, Alnylam Pharmaceuticals, Melvin "Skip" Olson, Global Head Real World Data Strategy & Innovation, Novartis, Carl de Moor, Senior Director & Head of Global RWE Strategy, Analytics & Biostatistics, Biogen

Share this event

Add to:

25/09/2018 08:00:00 27/09/2018 17:00:00 15 IMPACCT: RWE - Real World Evidence Conference <p>If you're actively invested in leveraging evidence to support drug development and commercialization, join the 6th annual IMPACCT:RWE 2018 meeting, where you will have an opportunity to explore ... Hilton Boston/Woburn, Woburn, Massachusetts 01801 Organizer Organizer e-mail false DD/MM/YYYY Reddit